Zobrazeno 1 - 10
of 10 907
pro vyhledávání: '"CHATENOUD, L."'
Autor:
Alagna, L., Palomba, E., Chatenoud, L., Massafra, R., Magni, F., Mancabelli, L., Donnini, S., Elli, F., Forastieri, A., Gaipa, G., Abbruzzese, C., Fumagalli, R., Munari, M., Panacea, A., Picetti, E., Terranova, L., Turroni, F., Vaschetto, R., Zoerle, T., Citerio, G., Gori, A., Bandera, A.
Publikováno v:
In Journal of Hospital Infection October 2023 140:90-95
Autor:
Chatenoud L; Université Paris Cité, CNRS, INSERM, Institut Necker Enfants Malades-INEM, Paris 75015, France lucienne.chatenoud@inserm.fr kevan.herold@yale.edu jbluestone@sonomabio.com., Herold KC; Departments of Immunobiology and Internal Medicine, Yale University, New Haven, Connecticut 06511, USA lucienne.chatenoud@inserm.fr kevan.herold@yale.edu jbluestone@sonomabio.com., Bach JF; Université Paris Cité, CNRS, INSERM, Institut Necker Enfants Malades-INEM, Paris 75015, France., Bluestone JA; Sonoma Biotherapeutics, South San Francisco, California 09080, USA lucienne.chatenoud@inserm.fr kevan.herold@yale.edu jbluestone@sonomabio.com.
Publikováno v:
Cold Spring Harbor perspectives in medicine [Cold Spring Harb Perspect Med] 2024 Sep 16. Date of Electronic Publication: 2024 Sep 16.
Autor:
Felten R; Service de Rhumatologie - Centre National de Référence des maladies auto-immuneset et auto-inflammatoires systémiques rares RESO, Hopitaux universitaires de Strasbourg, Strasbourg, France.; Immunologie, Immunopathologie et Chimie Thérapeutique, CNRS UPR 3572, IBMC, Strasbourg, France., Foray AP; Université Paris Cité, CNRS UMR 8253, INSERM UMR 1151, Institut Necker Enfants Malades-INEM, Paris, France., Schneider P; Department of Immunobiology, University of Lausanne, Lausanne, Switzerland., Marquet C; Université Paris Cité, CNRS UMR 8253, INSERM UMR 1151, Institut Necker Enfants Malades-INEM, Paris, France., Pecquet C; Université Paris Cité, CNRS UMR 8253, INSERM UMR 1151, Institut Necker Enfants Malades-INEM, Paris, France., Monneaux F; Immunologie, Immunopathologie et Chimie Thérapeutique, CNRS UPR 3572, IBMC, Strasbourg, France., Dumortier H; Immunologie, Immunopathologie et Chimie Thérapeutique, CNRS UPR 3572, IBMC, Strasbourg, France., Sibilia J; Service de Rhumatologie - Centre National de Référence des maladies auto-immuneset et auto-inflammatoires systémiques rares RESO, Hopitaux universitaires de Strasbourg, Strasbourg, France., Valette F; Université Paris Cité, CNRS UMR 8253, INSERM UMR 1151, Institut Necker Enfants Malades-INEM, Paris, France., Chatenoud L; Université Paris Cité, CNRS UMR 8253, INSERM UMR 1151, Institut Necker Enfants Malades-INEM, Paris, France., Gottenberg JE; Service de Rhumatologie - Centre National de Référence des maladies auto-immuneset et auto-inflammatoires systémiques rares RESO, Hopitaux universitaires de Strasbourg, Strasbourg, France jacques-eric.gottenberg@chru-strasbourg.fr.; Immunologie, Immunopathologie et Chimie Thérapeutique, CNRS UPR 3572, IBMC, Strasbourg, France.
Publikováno v:
RMD open [RMD Open] 2024 Aug 28; Vol. 10 (3). Date of Electronic Publication: 2024 Aug 28.
Autor:
Esposito G; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy. Electronic address: giovanna.esposito@unimi.it., Parazzini F; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy., Chatenoud L; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy., Santucci C; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy., La Vecchia C; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy., Negri E; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Publikováno v:
European journal of obstetrics, gynecology, and reproductive biology [Eur J Obstet Gynecol Reprod Biol] 2024 Aug; Vol. 299, pp. 32-36. Date of Electronic Publication: 2024 May 26.
Autor:
Calderon, D., Prot, M., You, S., Marquet, C., Bellamy, V., Bruneval, P., Valette, F., de Almeida, P., Wu, J.C., Pucéat, M., Menasché, P., Chatenoud, L. *
Publikováno v:
In American Journal of Transplantation February 2016 16(2):454-467
Autor:
Ramos EL; From Provention Bio, a Sanofi company, Red Bank, NJ (E.L.R., L.A.K., W.T.); Cardiff University, Cardiff, United Kingdom (C.M.D.); Université Paris Cité, CNRS, INSERM, Institut Necker Enfants Malades-INEM, Paris (L.C.); the Department of Pediatrics, Motol University Hospital, Second Faculty of Medicine-Charles University, Prague, Czech Republic (Z.S.); the Barbara Davis Center for Diabetes/University of Colorado School of Medicine, Aurora (K.M.S.); the Medical University of Warsaw, Warsaw, Poland (A.S.); the University of California, San Francisco, San Francisco (S.E.G.); Sanofi, Frankfurt, Germany (E.N.); and the Departments of Immunobiology and Internal Medicine, Yale University, New Haven, CT (K.C.H.)., Dayan CM; From Provention Bio, a Sanofi company, Red Bank, NJ (E.L.R., L.A.K., W.T.); Cardiff University, Cardiff, United Kingdom (C.M.D.); Université Paris Cité, CNRS, INSERM, Institut Necker Enfants Malades-INEM, Paris (L.C.); the Department of Pediatrics, Motol University Hospital, Second Faculty of Medicine-Charles University, Prague, Czech Republic (Z.S.); the Barbara Davis Center for Diabetes/University of Colorado School of Medicine, Aurora (K.M.S.); the Medical University of Warsaw, Warsaw, Poland (A.S.); the University of California, San Francisco, San Francisco (S.E.G.); Sanofi, Frankfurt, Germany (E.N.); and the Departments of Immunobiology and Internal Medicine, Yale University, New Haven, CT (K.C.H.)., Chatenoud L; From Provention Bio, a Sanofi company, Red Bank, NJ (E.L.R., L.A.K., W.T.); Cardiff University, Cardiff, United Kingdom (C.M.D.); Université Paris Cité, CNRS, INSERM, Institut Necker Enfants Malades-INEM, Paris (L.C.); the Department of Pediatrics, Motol University Hospital, Second Faculty of Medicine-Charles University, Prague, Czech Republic (Z.S.); the Barbara Davis Center for Diabetes/University of Colorado School of Medicine, Aurora (K.M.S.); the Medical University of Warsaw, Warsaw, Poland (A.S.); the University of California, San Francisco, San Francisco (S.E.G.); Sanofi, Frankfurt, Germany (E.N.); and the Departments of Immunobiology and Internal Medicine, Yale University, New Haven, CT (K.C.H.)., Sumnik Z; From Provention Bio, a Sanofi company, Red Bank, NJ (E.L.R., L.A.K., W.T.); Cardiff University, Cardiff, United Kingdom (C.M.D.); Université Paris Cité, CNRS, INSERM, Institut Necker Enfants Malades-INEM, Paris (L.C.); the Department of Pediatrics, Motol University Hospital, Second Faculty of Medicine-Charles University, Prague, Czech Republic (Z.S.); the Barbara Davis Center for Diabetes/University of Colorado School of Medicine, Aurora (K.M.S.); the Medical University of Warsaw, Warsaw, Poland (A.S.); the University of California, San Francisco, San Francisco (S.E.G.); Sanofi, Frankfurt, Germany (E.N.); and the Departments of Immunobiology and Internal Medicine, Yale University, New Haven, CT (K.C.H.)., Simmons KM; From Provention Bio, a Sanofi company, Red Bank, NJ (E.L.R., L.A.K., W.T.); Cardiff University, Cardiff, United Kingdom (C.M.D.); Université Paris Cité, CNRS, INSERM, Institut Necker Enfants Malades-INEM, Paris (L.C.); the Department of Pediatrics, Motol University Hospital, Second Faculty of Medicine-Charles University, Prague, Czech Republic (Z.S.); the Barbara Davis Center for Diabetes/University of Colorado School of Medicine, Aurora (K.M.S.); the Medical University of Warsaw, Warsaw, Poland (A.S.); the University of California, San Francisco, San Francisco (S.E.G.); Sanofi, Frankfurt, Germany (E.N.); and the Departments of Immunobiology and Internal Medicine, Yale University, New Haven, CT (K.C.H.)., Szypowska A; From Provention Bio, a Sanofi company, Red Bank, NJ (E.L.R., L.A.K., W.T.); Cardiff University, Cardiff, United Kingdom (C.M.D.); Université Paris Cité, CNRS, INSERM, Institut Necker Enfants Malades-INEM, Paris (L.C.); the Department of Pediatrics, Motol University Hospital, Second Faculty of Medicine-Charles University, Prague, Czech Republic (Z.S.); the Barbara Davis Center for Diabetes/University of Colorado School of Medicine, Aurora (K.M.S.); the Medical University of Warsaw, Warsaw, Poland (A.S.); the University of California, San Francisco, San Francisco (S.E.G.); Sanofi, Frankfurt, Germany (E.N.); and the Departments of Immunobiology and Internal Medicine, Yale University, New Haven, CT (K.C.H.)., Gitelman SE; From Provention Bio, a Sanofi company, Red Bank, NJ (E.L.R., L.A.K., W.T.); Cardiff University, Cardiff, United Kingdom (C.M.D.); Université Paris Cité, CNRS, INSERM, Institut Necker Enfants Malades-INEM, Paris (L.C.); the Department of Pediatrics, Motol University Hospital, Second Faculty of Medicine-Charles University, Prague, Czech Republic (Z.S.); the Barbara Davis Center for Diabetes/University of Colorado School of Medicine, Aurora (K.M.S.); the Medical University of Warsaw, Warsaw, Poland (A.S.); the University of California, San Francisco, San Francisco (S.E.G.); Sanofi, Frankfurt, Germany (E.N.); and the Departments of Immunobiology and Internal Medicine, Yale University, New Haven, CT (K.C.H.)., Knecht LA; From Provention Bio, a Sanofi company, Red Bank, NJ (E.L.R., L.A.K., W.T.); Cardiff University, Cardiff, United Kingdom (C.M.D.); Université Paris Cité, CNRS, INSERM, Institut Necker Enfants Malades-INEM, Paris (L.C.); the Department of Pediatrics, Motol University Hospital, Second Faculty of Medicine-Charles University, Prague, Czech Republic (Z.S.); the Barbara Davis Center for Diabetes/University of Colorado School of Medicine, Aurora (K.M.S.); the Medical University of Warsaw, Warsaw, Poland (A.S.); the University of California, San Francisco, San Francisco (S.E.G.); Sanofi, Frankfurt, Germany (E.N.); and the Departments of Immunobiology and Internal Medicine, Yale University, New Haven, CT (K.C.H.)., Niemoeller E; From Provention Bio, a Sanofi company, Red Bank, NJ (E.L.R., L.A.K., W.T.); Cardiff University, Cardiff, United Kingdom (C.M.D.); Université Paris Cité, CNRS, INSERM, Institut Necker Enfants Malades-INEM, Paris (L.C.); the Department of Pediatrics, Motol University Hospital, Second Faculty of Medicine-Charles University, Prague, Czech Republic (Z.S.); the Barbara Davis Center for Diabetes/University of Colorado School of Medicine, Aurora (K.M.S.); the Medical University of Warsaw, Warsaw, Poland (A.S.); the University of California, San Francisco, San Francisco (S.E.G.); Sanofi, Frankfurt, Germany (E.N.); and the Departments of Immunobiology and Internal Medicine, Yale University, New Haven, CT (K.C.H.)., Tian W; From Provention Bio, a Sanofi company, Red Bank, NJ (E.L.R., L.A.K., W.T.); Cardiff University, Cardiff, United Kingdom (C.M.D.); Université Paris Cité, CNRS, INSERM, Institut Necker Enfants Malades-INEM, Paris (L.C.); the Department of Pediatrics, Motol University Hospital, Second Faculty of Medicine-Charles University, Prague, Czech Republic (Z.S.); the Barbara Davis Center for Diabetes/University of Colorado School of Medicine, Aurora (K.M.S.); the Medical University of Warsaw, Warsaw, Poland (A.S.); the University of California, San Francisco, San Francisco (S.E.G.); Sanofi, Frankfurt, Germany (E.N.); and the Departments of Immunobiology and Internal Medicine, Yale University, New Haven, CT (K.C.H.)., Herold KC; From Provention Bio, a Sanofi company, Red Bank, NJ (E.L.R., L.A.K., W.T.); Cardiff University, Cardiff, United Kingdom (C.M.D.); Université Paris Cité, CNRS, INSERM, Institut Necker Enfants Malades-INEM, Paris (L.C.); the Department of Pediatrics, Motol University Hospital, Second Faculty of Medicine-Charles University, Prague, Czech Republic (Z.S.); the Barbara Davis Center for Diabetes/University of Colorado School of Medicine, Aurora (K.M.S.); the Medical University of Warsaw, Warsaw, Poland (A.S.); the University of California, San Francisco, San Francisco (S.E.G.); Sanofi, Frankfurt, Germany (E.N.); and the Departments of Immunobiology and Internal Medicine, Yale University, New Haven, CT (K.C.H.).
Publikováno v:
The New England journal of medicine [N Engl J Med] 2023 Dec 07; Vol. 389 (23), pp. 2151-2161. Date of Electronic Publication: 2023 Oct 18.
Autor:
Chatenoud, L. *, Bertuccio, P., Bosetti, C., Malvezzi, M., Levi, F., Negri, E., La Vecchia, C.
Publikováno v:
In Annals of Oncology September 2014 25(9):1843-1853
Autor:
Sicard, A., Amrouche, L., Suberbielle, C., Carmagnat, M., Candon, S., Thervet, E., Delahousse, M., Legendre, C., Chatenoud, L., Snanoudj, R. *
Publikováno v:
In American Journal of Transplantation January 2014 14(1):193-201
Autor:
Bestard, O. *, Crespo, E., Stein, M., Lúcia, M., Roelen, D.L., de Vaal, Y.J., Hernandez-Fuentes, M.P., Chatenoud, L., Wood, K.J., Claas, F.H., Cruzado, J.M., Grinyó, J.M., Volk, H.D., Reinke, P.
Publikováno v:
In American Journal of Transplantation July 2013 13(7):1880-1890
Publikováno v:
In American Journal of Transplantation July 2013 13(7):1655-1664